Lorenz Scheppler

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch, Frank Tomaka, Frank Wegmann et al. · The Lancet · 2018 · 334 citations · Full text

Vaccination, Vaccine Development, Nhp 13-19 +9

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

Lindsey R. Baden, Daniel J Stieh, Michal Sarnecki et al. · The Lancet HIV · 2020 · 90 citations · Full text

Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle

Lorenz Scheppler · Vaccine · 2002 · 76 citations

Vaccination, Mucosal Vaccination, Vaccine Development +5

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

Glenda Gray, Kathryn Mngadi, Ludo Lavreys et al. · The Lancet Infectious Diseases · 2024 · 29 citations · Full text

Intranasal immunisation using recombinant Lactobacillus johnsonii as a new strategy to prevent allergic disease

Lorenz Scheppler, Monique Vogel, Pamela Marti et al. · Vaccine · 2004 · 18 citations

Vaccination, Mucosal Vaccination, Vaccine Development +11